 Alzheimer Disease
"Alzheimer Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Descriptor ID |
D000544
|
| MeSH Number(s) |
C10.228.140.380.100 C10.574.945.249 F03.087.400.100
|
| Concept/Terms |
Alzheimer Disease- Alzheimer Disease
- Disease, Alzheimer
- Alzheimer's Disease
- Disease, Alzheimer's
- Primary Senile Degenerative Dementia
- Dementia, Alzheimer Type
- Alzheimer Type Dementia
- Senile Dementia, Alzheimer Type
- Alzheimer Type Senile Dementia
- Dementia, Primary Senile Degenerative
- Dementia, Senile
- Dementias, Senile
- Senile Dementia
- Senile Dementias
Dementia, Presenile- Dementia, Presenile
- Dementias, Presenile
- Presenile Dementia
- Presenile Dementias
Alzheimer Disease, Early Onset- Alzheimer Disease, Early Onset
- Early Onset Alzheimer Disease
- Presenile Alzheimer Dementia
- Alzheimer Dementia, Presenile
- Dementia, Presenile Alzheimer
|
Below are MeSH descriptors whose meaning is more general than "Alzheimer Disease".
Below are MeSH descriptors whose meaning is more specific than "Alzheimer Disease".
This graph shows the total number of publications written about "Alzheimer Disease" by people in this website by year, and whether "Alzheimer Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 0 | 1 | | 1985 | 1 | 1 | 2 | | 1988 | 3 | 0 | 3 | | 1989 | 1 | 0 | 1 | | 1990 | 5 | 0 | 5 | | 1991 | 10 | 0 | 10 | | 1992 | 6 | 1 | 7 | | 1993 | 6 | 3 | 9 | | 1994 | 8 | 3 | 11 | | 1995 | 4 | 3 | 7 | | 1996 | 13 | 1 | 14 | | 1997 | 10 | 3 | 13 | | 1998 | 8 | 8 | 16 | | 1999 | 10 | 3 | 13 | | 2000 | 6 | 5 | 11 | | 2001 | 5 | 4 | 9 | | 2002 | 8 | 3 | 11 | | 2003 | 7 | 4 | 11 | | 2004 | 11 | 1 | 12 | | 2005 | 9 | 5 | 14 | | 2006 | 8 | 3 | 11 | | 2007 | 5 | 2 | 7 | | 2008 | 2 | 6 | 8 | | 2009 | 2 | 1 | 3 | | 2010 | 6 | 5 | 11 | | 2011 | 4 | 5 | 9 | | 2012 | 2 | 1 | 3 | | 2013 | 10 | 1 | 11 | | 2014 | 1 | 1 | 2 | | 2015 | 0 | 2 | 2 | | 2016 | 3 | 2 | 5 | | 2017 | 9 | 1 | 10 | | 2018 | 7 | 1 | 8 | | 2019 | 6 | 1 | 7 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Alzheimer Disease" by people in Profiles.
-
Despa F, Goldstein LB, Biessels GJ. Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease. Ann Neurol. 2020 03; 87(3):486.
-
Yu L, Wei F, Liang J, Ren G, Liu X, Wang CZ, Yuan J, Zeng J, Luo Y, Bi Y, Yuan CS. Target Molecular-Based Neuroactivity Screening and Analysis of Panax ginseng by Affinity Ultrafiltration, UPLC-QTOF-MS and Molecular Docking. Am J Chin Med. 2019; 47(6):1345-1363.
-
Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, Montine TJ, Schellenberg GD, Deming Y, Chao MJ, Huentelman M, Martin ER, Hamilton-Nelson K, Shaw LM, Trojanowski JQ, Peskind ER, Cruchaga C, Pericak-Vance MA, Goate AM, Cox NJ, Haines JL, Zetterberg H, Blennow K, Larson EB, Johnson SC, Albert M. Sex differences in the genetic predictors of Alzheimer's pathology. Brain. 2019 09 01; 142(9):2581-2589.
-
Fu CH, Iascone DM, Petrof I, Hazra A, Zhang X, Pyfer MS, Tosi U, Corbett BF, Cai J, Lee J, Park J, Iacovitti L, Scharfman HE, Enikolopov G, Chin J. Early Seizure Activity Accelerates Depletion of Hippocampal Neural Stem Cells and Impairs Spatial Discrimination in an Alzheimer's Disease Model. Cell Rep. 2019 06 25; 27(13):3741-3751.e4.
-
Ortega-Martinez S, Palla N, Zhang X, Lipman E, Sisodia SS. Deficits in Enrichment-Dependent Neurogenesis and Enhanced Anxiety Behaviors Mediated by Expression of Alzheimer's Disease-Linked Ps1 Variants Are Rescued by Microglial Depletion. J Neurosci. 2019 08 21; 39(34):6766-6780.
-
Qin K, Zhao L, Gregory C, Solanki A, Mastrianni JA. "Dual Disease" TgAD/GSS mice exhibit enhanced Alzheimer's disease pathology and reveal PrPC-dependent secretion of Aß. Sci Rep. 2019 06 12; 9(1):8524.
-
Deyts C, Clutter M, Pierce N, Chakrabarty P, Ladd TB, Goddi A, Rosario AM, Cruz P, Vetrivel K, Wagner SL, Thinakaran G, Golde TE, Parent AT. APP-Mediated Signaling Prevents Memory Decline in Alzheimer's Disease Mouse Model. Cell Rep. 2019 04 30; 27(5):1345-1355.e6.
-
Franz CE, Xian H, Lew D, Hatton SN, Puckett O, Whitsel N, Beck A, Dale AM, Fang B, Fennema-Notestine C, Hauger RL, Jacobson KC, Lyons MJ, Reynolds CA, Kremen WS. Body mass trajectories and cortical thickness in middle-aged men: a 42-year longitudinal study starting in young adulthood. Neurobiol Aging. 2019 07; 79:11-21.
-
Andrew RJ, De Rossi P, Nguyen P, Kowalski HR, Recupero AJ, Guerbette T, Krause SV, Rice RC, Laury-Kleintop L, Wagner SL, Thinakaran G. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model. J Biol Chem. 2019 03 22; 294(12):4477-4487.
-
De Rossi P, Andrew RJ, Musial TF, Buggia-Prevot V, Xu G, Ponnusamy M, Ly H, Krause SV, Rice RC, de l'Estoile V, Valin T, Salem S, Despa F, Borchelt DR, Bindokas VP, Nicholson DA, Thinakaran G. Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models. Brain Pathol. 2019 07; 29(4):485-501.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|